Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words '3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 193 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kavanagh, P; Dunne, J; Feely, J; Maguire, R; Corrigan, D; Keating, JJ; Meegan, MJ; Clancy, JM; Burdett, J
      Phenylalkylamine abuse among opiate addicts attending a methadone treatment programme in the Republic of Ireland

      ADDICTION BIOLOGY
    2. Frei, E; Gamma, A; Pascual-Marqui, R; Lehmann, D; Hell, D; Vollenweider, FX
      Localization of MDMA-induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (LORETA)

      HUMAN BRAIN MAPPING
    3. Maldonado, E; Navarro, JF
      MDMA ('ecstasy') exhibits an anxiogenic-like activity in social encountersbetween male mice

      PHARMACOLOGICAL RESEARCH
    4. Obergriesser, T; Ende, G; Braus, DF; Henn, FA
      Hippocampal H-1-MRSI in ecstasy users

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    5. Zemishlany, Z; Aizenberg, D; Weizman, A
      Subjective effects of MDMA ('ecstasy') on human sexual function

      EUROPEAN PSYCHIATRY
    6. Wrona, MZ; Dryhurst, G
      A putative metabolite of serotonin, tryptamine-4,5-dione, is an irreversible inhibitor of tryptophan hydroxylase: Possible relevance to the serotonergic neurotoxicity of methamphetamine

      CHEMICAL RESEARCH IN TOXICOLOGY
    7. Bai, FJ; Jones, DC; Lau, SS; Monks, TJ
      Serotonergic neurotoxicity of 3,4-(+/-) -methylenedioxyamphetamine and 3,4-(+/-)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase

      CHEMICAL RESEARCH IN TOXICOLOGY
    8. Fletcher, PJ; Robinson, SR; Slippoy, DL
      Pre-exposure to (+/-)3,4-methylenedioxy-methamphetamine (MDMA) facilitatesacquisition of intravenous cocaine self-administration in rats

      NEUROPSYCHOPHARMACOLOGY
    9. Taffe, MA; Weed, MR; Davis, S; Huitron-Resendiz, S; Schroeder, R; Parsons, LH; Henriksen, SJ; Gold, LH
      Functional consequences of repeated (+/-)3,4-methylenedioxymethamphetamine(MDMA) treatment in rhesus monkeys

      NEUROPSYCHOPHARMACOLOGY
    10. Liechti, ME; Geyer, MA; Hell, D; Vollenweider, FX
      Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin

      NEUROPSYCHOPHARMACOLOGY
    11. Callahan, BT; Cord, BJ; Ricaurte, GA
      Long-term impairment of anterograde axonal transport along fiber projection originating in the rostral raphe nuclei after treatment with fenfluramineor methylenedioxymethamphetamine

      SYNAPSE
    12. Kalant, H
      The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    13. Tancer, ME; Johanson, CE
      The subjective effects of MDMA and mCPP in moderate MDMA users

      DRUG AND ALCOHOL DEPENDENCE
    14. Fernandez, F; Aguerre, S; Mormede, P; Chaouloff, F
      Differential sensitivities to the lethal, but not the neurotoxic, effects of p-chloroamphetamine in inbred rat strains

      NEUROSCIENCE LETTERS
    15. Pentney, AR
      An exploration of the history and controversies surrounding MDMA and MDA

      JOURNAL OF PSYCHOACTIVE DRUGS
    16. Teter, CJ; Guthrie, SK
      A comprehensive review of MDMA and GHB: Two common club drugs

      PHARMACOTHERAPY
    17. Broening, HW; Morford, LL; Inman-Wood, SL; Fukumura, M; Vorhees, CV
      3,4-Methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development

      JOURNAL OF NEUROSCIENCE
    18. MacInnes, N; Handley, SL; Harding, GFA
      Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms

      JOURNAL OF PSYCHOPHARMACOLOGY
    19. Connor, TJ; Connelly, DB; Kelly, JP
      Methylenedioxymethamphetamine (MDMA; 'Ecstasy') suppresses antigen specific IgG(2a) and IFN-gamma production

      IMMUNOLOGY LETTERS
    20. Zhao, HR; Brenneisen, R; Scholer, A; McNally, AJ; ElSohly, MA; Murphy, TP; Salamone, SJ
      Profiles of urine samples taken from ecstasy users at rave parties: Analysis by immunoassays, HPLC, and GC-MS

      JOURNAL OF ANALYTICAL TOXICOLOGY
    21. Buchert, R; Obrocki, J; Thomasius, R; Vaterlein, O; Petersen, K; Jenicke, L; Bohuslavizki, KH; Clausen, M
      Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET

      NUCLEAR MEDICINE COMMUNICATIONS
    22. Gold, MS; Tabrah, H; Frost-Pineda, K
      Psychopharmacology of MDMA (Ecstasy)

      PSYCHIATRIC ANNALS
    23. O'Shea, E; Esteban, B; Camarero, J; Green, AR; Colado, MI
      Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain

      NEUROPHARMACOLOGY
    24. Ling, LH; Marchant, C; Buckley, NA; Prior, M; Irvine, RJ
      Poisoning with the recreational drug paramethoxyamphetamine ("death")

      MEDICAL JOURNAL OF AUSTRALIA
    25. Harkin, A; Connor, TJ; Mulrooney, J; Kelly, JP; Leonard, BE
      Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats

      LIFE SCIENCES
    26. Sanchez, V; Camarero, J; Esteban, B; Peter, MJ; Green, AR; Colado, MI
      The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain

      BRITISH JOURNAL OF PHARMACOLOGY
    27. Yamada, J; Sugimoto, Y; Ohkura, M; Inoue, K; Shinozuka, K; Kunitomo, M
      Role of 5-HT2 receptor subtypes in depletion of 5-HT induced by p-chloroamphetamine in the mouse frontal cortex

      BRAIN RESEARCH
    28. McCann, UD; Ricaurte, GA; Molliver, ME
      "Ecstasy" and serotonin neurotoxicity - New findings raise more questions

      ARCHIVES OF GENERAL PSYCHIATRY
    29. Lin, CH; Chung, YL; Chen, YH
      Development of a capillary electrophoresis-77 K luminescence detection system for online spectral identification

      ANALYST
    30. Croft, RJ; Klugman, A; Baldeweg, T; Gruzelier, JH
      Electrophysiological evidence of serotonergic impairment in long-term MDMA("ecstasy") users

      AMERICAN JOURNAL OF PSYCHIATRY
    31. Colado, MI; O'Shea, E; Esteban, B; Green, AR
      Studies on the neuroprotective effect of the enantiomers of AR-A008055, a compound structurally related to clomethiazole, on MDMA ("ecstasy")-inducedneurodegeneration in rat brain

      PSYCHOPHARMACOLOGY
    32. Liechti, ME; Gamma, A; Vollenweider, FX
      Gender differences in the subjective effects of MDMA

      PSYCHOPHARMACOLOGY
    33. Croft, RJ; Mackay, AJ; Mills, ATD; Gruzelier, JGH
      The relative contributions of ecstasy and cannabis to cognitive impairment

      PSYCHOPHARMACOLOGY
    34. Verkes, RJ; Gijsman, HJ; Pieters, MSM; Schoemaker, RC; de Visser, S; Kuijpers, M; Pennings, EJM; de Bruin, D; Van de Wijngaart, G; Van Gerven, JMA; Cohen, AF
      Cognitive performance and serotonergic function in users of ecstasy

      PSYCHOPHARMACOLOGY
    35. Van Aerts, LAGJM; Mallaret, M; Rigter, H
      N-methyl-1-(1,3-benzodioxol-5-yl)-2-buta (MBDB): its properties and possible risks

      ADDICTION BIOLOGY
    36. Grob, CS
      Deconstructing ecstasy: The politics of MDMA research

      ADDICTION RESEARCH
    37. Gamma, A; Frei, E; Lehmann, D; Pascual-Marqui, RD; Hell, D; Vollenweider, FX
      Mood state and brain electric activity in Ecstasy users

      NEUROREPORT
    38. Fischer, HS; Zernig, G; Schatz, DS; Humpel, C; Saria, A
      MDMA ('ecstasy') enhances basal acetylcholine release in brain slices of the rat striatum

      EUROPEAN JOURNAL OF NEUROSCIENCE
    39. McCann, UD; Ricaurte, GA
      Drug abuse and dependence: hazards and consequences of heroin, cocaine andamphetamines

      CURRENT OPINION IN PSYCHIATRY
    40. Buchler, J; Maichle-Mossmer, C; Kovar, KA
      Enantioselective production and crystal structure of the ecstasy analogue N-ethyl-3,4-methylenedioxyamphetamine-HCl (MDE) and its major metabolites MDA and HME

      ZEITSCHRIFT FUR NATURFORSCHUNG SECTION B-A JOURNAL OF CHEMICAL SCIENCES
    41. Burgess, C; O'Donohoe, A; Gill, M
      Agony and ecstasy: a review of MDMA effects and toxicity

      EUROPEAN PSYCHIATRY
    42. Dulawa, SC; Gross, C; Stark, KL; Hen, R; Geyer, MA
      Knockout mice reveal opposite roles for serotonin 1A and 1B receptors in prepulse inhibition

      NEUROPSYCHOPHARMACOLOGY
    43. Schatz, DS; Kaufmann, WA; Schuligoi, R; Humpel, C; Saria, A
      3,4-methylenedioxymetamphetamine (ecstasy) induces c-fos-like protein and mRNA in rat organotypic dorsal striatal slices

      SYNAPSE
    44. Shannon, M
      Methylenedioxymethamphetamine (MDMA, "Ecstasy")

      PEDIATRIC EMERGENCY CARE
    45. Graeme, KA
      New drugs of abuse

      EMERGENCY MEDICINE CLINICS OF NORTH AMERICA
    46. Ricaurte, GA; McCann, UD; Szabo, Z; Scheffel, U
      Toxicodynamics and long-term toxicity of the recreational drug, 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy')

      TOXICOLOGY LETTERS
    47. Parrott, AC; Sisk, E; Turner, JJD
      Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users

      DRUG AND ALCOHOL DEPENDENCE
    48. Ricaurte, GA; Yuan, J; McCann, UD
      (+/-)3,4-methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: Studies in animals

      NEUROPSYCHOBIOLOGY
    49. Parrott, AC
      Human research on MDMA (3,4-methylenedioxymethamphetamine) neurotoxicity: Cognitive and behavioural indices of change

      NEUROPSYCHOBIOLOGY
    50. Curran, HV
      Is MDMA ('ecstasy') neurotoxic in humans? An overview of evidence and of methodological problems in research

      NEUROPSYCHOBIOLOGY
    51. Maldonado, E; Navarro, JF
      Effects of 3,4-methylenedioxy-methamphetamine (MDMA) on anxiety in mice tested in the light-dark box

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    52. Xie, T; McCann, UD; Kim, S; Yuan, J; Ricaurte, GA
      Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: Implications for methamphetamine-induced dopaminergic neurotoxicity

      JOURNAL OF NEUROSCIENCE
    53. Erdtmann-Vourliotis, M; Mayer, P; Riechert, U; Hollt, V
      Prior experience of morphine application alters the c-fos response to MDMA('ecstasy') and cocaine in the rat striatum

      MOLECULAR BRAIN RESEARCH
    54. Conner, TJ; Kelly, JP; Leonard, BE
      An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats

      IMMUNOPHARMACOLOGY
    55. Valentine, JL; Middleton, R
      GC-MS identification of sympathomimetic amine drugs in urine: Rapid methodology applicable for emergency clinical toxicology

      JOURNAL OF ANALYTICAL TOXICOLOGY
    56. Boot, BP; McGregor, LS; Hall, W
      MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks

      LANCET
    57. Beitia, G; Cobreros, A; Sainz, L; Cenarruzabeitia, E
      Ecstasy-induced toxicity in rat liver

      LIVER
    58. Kelly, PAT
      Does recreational ecstasy use cause long-term cognitive problems?

      WESTERN JOURNAL OF MEDICINE
    59. Glennon, RA; Young, R
      MDMA stimulus generalization to the 5-HT1A serotonin agonist 8-hydroxy-2-(di-n-propylamino)tetralin

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    60. Byrne, T; Baker, LE; Poling, A
      MDMA and learning: Effects of acute and neurotoxic exposure in the rat

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    61. Barrionuevo, M; Aguirre, N; Del Rio, J; Lasheras, B
      Serotonergic deficits and impaired passive-avoidance learning in rats by MDEA: A comparison with MDMA

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    62. O'Cain, PA; Hletko, SB; Ogden, BA; Varner, KJ
      Cardiovascular and sympathetic responses and reflex changes elicited by MDMA

      PHYSIOLOGY & BEHAVIOR
    63. Connor, TJ; Kelly, JP; McGee, M; Leonard, BE
      Methylenedioxymethamphetamine (MDMA; Ecstasy) suppresses IL-1 beta and TNF-alpha secretion following an in vivo lipopolysaccharide challenge

      LIFE SCIENCES
    64. Kelly, PAT
      Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    65. Gouzoulis-Mayfrank, E; Daumann, J; Tuchtenhagen, F; Pelz, S; Becker, S; Kunert, HJ; Fimm, B; Sass, H
      Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    66. Morley, KC; McGregor, IS
      (+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases socialinteraction in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    67. Shirayama, Y; Hashimoto, K; Iyo, M; Watanabe, K; Higuchi, T; Minabe, Y
      3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA in rat brain: pharmacological manipulation

      EUROPEAN JOURNAL OF PHARMACOLOGY
    68. Kalia, M; O'Callaghan, JP; Miller, DB; Kramer, M
      Comparative study of fluoxetine, sibutramine, sertraline and dexfenfluramine on the morphology of serotonergic nerve terminals using serotonin immunohistochemistry

      BRAIN RESEARCH
    69. Gerra, G; Zaimovic, A; Ferri, M; Zambelli, U; Timpano, M; Neri, E; Marzocchi, GF; Delsignore, R; Brambilla, F
      Long-lasting effects of (+/-)3,4-methylene-dioxymethamphetamine (ecstasy) on serotonin system function in humans

      BIOLOGICAL PSYCHIATRY
    70. Kreth, KP; Kovar, KA; Schwab, M; Zanger, UM
      Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugs

      BIOCHEMICAL PHARMACOLOGY
    71. Morgan, MJ
      Ecstasy (MDMA): a review of its possible persistent psychological effects

      PSYCHOPHARMACOLOGY
    72. Sexton, TJ; McEvoy, C; Neumaier, JF
      (+)3,4-Methylenedioxymethamphetamine ('ecstasy') transiently increases striatal 5-HT1B binding sites without altering 5-HT1B mRNA in rat brain

      MOLECULAR PSYCHIATRY
    73. Chang, L; Ernst, T; Grob, CS; Poland, RE
      Cerebral H-1 MRS alterations in recreational 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") users

      JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING
    74. Walubo, A; Seger, D
      Fatal multi-organ failure after suicidal overdose with MDMA, 'Ecstasy': case report and review of the literature

      HUMAN & EXPERIMENTAL TOXICOLOGY
    75. Aguirre, N; Barrionuevo, M; Ramirez, MJ; Del Rio, J; Lasheras, B
      alpha-lipoic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity

      NEUROREPORT
    76. Virden, TB; Baker, LE
      Disruption of the discriminative stimulus effects of S(+)-3,4-methylenedioxymethamphetamine (MDMA) by (+/-)-MDMA neurotoxicity: protection by fluoxetine

      BEHAVIOURAL PHARMACOLOGY
    77. Colado, MI; Granados, R; O'Shea, E; Esteban, B; Green, AR
      The acute effect in rats of 3,4-methylenedioxyethamphetamine (MDEA,"eve") on body temperature and long term degeneration of 5-HT neurones in brain: Acomparison with MDMA ("ecstasy")

      PHARMACOLOGY & TOXICOLOGY
    78. Stumm, G; Schlegel, J; Schafer, T; Wurz, C; Mennel, HD; Krieg, JC; Vedder, H
      Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons

      FASEB JOURNAL
    79. RATTRAY M; MICHAEL GJ; LEE J; WOTHERSPOON G; BENDOTTI C; PRIESTLEY JV
      INTRAREGIONAL VARIATION IN EXPRESSION OF SEROTONIN TRANSPORTER MESSENGER-RNA BY 5-HYDROXYTRYPTAMINE NEURONS

      Neuroscience
    80. Jayanthi, S; Ladenheim, B; Andrews, AM; Cadet, JL
      Overexpression of human copper zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphetamine (ecstasy)

      NEUROSCIENCE
    81. Navarro, JF; Maldonado, E
      Behavioral, profile of 3,4-methylenedioxy-methamphetamine (MDMA) in agonistic encounters between male mice

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    82. Hatzidimitriou, G; McCann, UD; Ricaurte, GA
      Altered serotonin innervation patterns in the forebrain of monkeys treatedwith (+/--)3,4-methylenedioxymethamphetamine seven years previously: Factors influencing abnormal recovery

      JOURNAL OF NEUROSCIENCE
    83. Hegadoren, KM; Baker, GB; Bourin, M
      3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans

      NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
    84. Hensley, D; Cody, JT
      Simultaneous determination of amphetamine, methamphetamine, methylenedioxyamphetamine (MDA), methylenedioxymethamphetamine (MDMA), and methylenedioxyethylamphetamine (MDEA) enantiomers by GC-MS

      JOURNAL OF ANALYTICAL TOXICOLOGY
    85. Malpass, A; White, JM; Irvine, RJ; Somogyi, AA; Bochner, F
      Acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA) in Sprague-Dawley and Dark Agouti rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    86. Rocher, C; Jacquot, C; Gardier, AM
      Simultaneous effects of local dexfenfluramine application on extracellularglutamate and serotonin levels in rat frontal cortex: a reverse microdialysis study

      NEUROPHARMACOLOGY
    87. Colado, MI; O'Shea, E; Esteban, B; Granados, R; Green, AR
      In vivo evidence against clomethiazole being neuroprotective against MDMA ('ecstasy')-induced degeneration of rat brain 5-HT nerve terminals by a free radical scavenging mechanism

      NEUROPHARMACOLOGY
    88. Felgenhauer, N; Zilker, T
      Intoxication with amphetamines and designer drugs

      INTERNIST
    89. Shankaran, H; Yamamoto, BK; Gudelsky, GA
      Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine

      EUROPEAN JOURNAL OF PHARMACOLOGY
    90. Cozzi, NV; Sievert, MK; Shulgin, AT; Jacob, P; Ruoho, AE
      Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines

      EUROPEAN JOURNAL OF PHARMACOLOGY
    91. Hammersley, R; Ditton, J; Smith, I; Short, E
      Patterns of ecstasy use by drug users

      BRITISH JOURNAL OF CRIMINOLOGY
    92. McCann, UD; Eligulashvili, V; Mertl, M; Murphy, DL; Ricaurte, GA
      Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users

      PSYCHOPHARMACOLOGY
    93. Shankaran, M; Gudelsky, GA
      A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration

      PSYCHOPHARMACOLOGY
    94. Marston, HM; Reid, ME; Lawrence, JA; Olverman, HJ; Butcher, SP
      Behavioural analysis of the acute and chronic effects of MDMA treatment inthe rat

      PSYCHOPHARMACOLOGY
    95. Vollenweider, FX; Remensberger, S; Hell, D; Geyer, MA
      Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans

      PSYCHOPHARMACOLOGY
    96. McCann, UD; Mertl, M; Eligulashvili, V; Ricaurte, GA
      Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study

      PSYCHOPHARMACOLOGY
    97. Colado, MI; Esteban, B; O'Shea, E; Granados, R; Green, AR
      Studies on the neuroprotective effect at pentobarbitone on MDMA-induced neurodegeneration

      PSYCHOPHARMACOLOGY
    98. Gouzoulis-Mayfrank, E; Thelen, B; Habermeyer, E; Kunert, HJ; Kovar, KA; Lindenblatt, H; Hermle, L; Spitzer, M; Sass, H
      Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers - Results of an experimental double blind placebo controlled study

      PSYCHOPHARMACOLOGY
    99. Scearce-Levie, K; Viswanathan, SS; Hen, R
      Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor

      PSYCHOPHARMACOLOGY
    100. Morgan, MJ
      Memory deficits associated with recreational use of "ecstasy" (MDMA)

      PSYCHOPHARMACOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/12/19 alle ore 14:44:27